Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15822 articles
Low preoperative prognostic nutritional index predicts poor survival in patients with newly diagnosed high-grade gliomas.
Both PFS and OS were better for the patients with high PNI.
»
07/14/16
Bioinformatic identification of prognostic signature defined by copy number alteration and expression of CCNE1 in non-muscle invasive bladder cancer.
NMIBC progression is potentially mediated by CCND1-CCNE1-SP1 pathways.
»
04/12/16
Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer.
Serum LDH may be a marker of tumour angiogenesis activation.
»
08/08/16
Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samples.
Significant associations with clinico-pathological features related to prognosis were found for several candidates.
»
07/20/16
Abiraterone or Enzalutamide in Advanced Castration-Resistant Prostate Cancer: An Indirect Comparison.
Enzalutamide outperforms AA with prednisone in terms of OS.
»
11/24/16
Cisplatin can be safely administered to ovarian cancer patients with hypersensitivity to carboplatin.
Cisplatin rechallenge is a feasible approach in patients experiencing HSR to carboplatin.
»
08/22/16
The cessation of anti-PD-1 antibodies of complete responders in metastatic melanoma.
The median time to CR was 10.5 months in the PEM NPP.
»
01/19/17
Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Patients With Stage I Non-Small-Cell Lung Cancer: A Competing Risks Analysis.
Noncancer-specific mortality is a significant competing event, with an increasing impact as patient age increases.
»
01/18/17
MicroRNA-187 promotes growth and metastasis of gastric cancer by inhibiting FOXA2.
FOXA2 downstream target of miR-187 in GC cells.
»
06/21/16
Msi1 Promotes Tumor Progression by Epithelial-to-Mesenchymal Transition in Cervical Cancer.
Msi1 promoted the EMT progression through activation of the Wnt signaling pathway.
»
09/29/16
< Prev
Next >